Wheeler, H., Bacha, J., Kanekal, S., Pedersen, H., Sankar, N., Wang, S., . . . Brown, D. (2020). 70. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE pan-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION. Neurooncol Adv.

Wheeler, Helen, Jeffrey Bacha, Sarath Kanekal, Harry Pedersen, Neil Sankar, Shen Wang, Ian Nesbit, Kathy Skoff, and Dennis Brown. "70. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE Pan-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION." Neurooncol Adv 2020.

Wheeler, Helen, et al. "70. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE Pan-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION." Neurooncol Adv 2020.